No study has directly demonstrated that mold exposure causes Sjögren’s syndrome. The disease is recognized as autoimmune, driven by a combination of genetic susceptibility and environmental triggers, and while mold is increasingly discussed as one of many possible environmental contributors, the specific link remains unproven. What does exist is a set of plausible biological pathways connecting mold and mycotoxin exposure to the kind of immune disruption seen in Sjögren’s, along with scattered epidemiological observations that raise questions without settling them.
What Actually Drives Sjögren’s Syndrome
Sjögren’s syndrome targets the body’s moisture-producing glands, especially those responsible for tears and saliva. Chronic inflammation in these glands leads to the hallmark dryness of the eyes and mouth, but the disease can also affect joints, lungs, kidneys, and nerves. At its core, the immune system misfires: it produces autoantibodies and sends immune cells to attack the body’s own tissue. Persistent overactivation of the type I interferon system and the involvement of autoreactive B and T cells are central to how the disease develops.1PubMed. Environmental factors in the pathogenesis of primary Sjögren’s syndrome
Genetics matter, but they do not tell the whole story. Several gene variants have been linked to higher Sjögren’s risk, though each one contributes only a modest increase. Researchers have concluded that genetics alone cannot account for the disease and that external, environmental factors must play a critical role in pushing a genetically susceptible person toward full-blown illness.1PubMed. Environmental factors in the pathogenesis of primary Sjögren’s syndrome
A systematic review and meta-analysis of risk factors for primary Sjögren’s syndrome found that prior infection carried roughly a threefold increase in risk, having a first-degree relative with any autoimmune disease raised risk nearly sixfold, and experiencing negative stressful life events was also associated with higher odds of developing the disease.2PubMed Central. Risk factors for primary Sjögren’s Syndrome: a systematic review and meta-analysis These findings reinforce the idea that the immune system needs a push from the outside world to tip into autoimmunity. The question is whether mold can be one of those pushes.
How Mold and Mycotoxins Disrupt the Immune System
Molds produce secondary metabolites called mycotoxins, and these compounds are not biologically inert. They interact with the immune system in two seemingly contradictory ways. Some mycotoxins suppress immune function by triggering oxidative stress and killing immune cells through programmed cell death. Others stimulate the immune system by directly activating inflammatory signaling pathways.3Food and Chemical Toxicology. An update on immunotoxicity and mechanisms of action of six environmental mycotoxins This dual capacity is part of what makes mycotoxin exposure unpredictable: in one context it might leave a person more vulnerable to infection, and in another it might ramp up inflammatory responses in ways the body did not intend.
One of the specific inflammatory mechanisms involves the NLRP3 inflammasome, a protein complex that acts as an alarm system inside cells. When mycotoxins activate it, the result is tissue damage and inflammation. Research has linked exposure to several common mycotoxins, including deoxynivalenol, aflatoxin B1, and ochratoxin A, to activation of this inflammasome and downstream release of pro-inflammatory signals.4PubMed Central. The Novel Role of the NLRP3 Inflammasome in Mycotoxin-Induced Toxicological Mechanisms The NLRP3 inflammasome has been implicated in a variety of autoimmune and chronic inflammatory conditions, so its activation by mold-derived toxins is at least mechanistically relevant to the autoimmune conversation.
The immune disruption does not stop at acute inflammation. Mycotoxins have also been shown to alter gene expression through epigenetic changes, meaning they can modify how DNA is read without changing the genetic code itself. These changes include shifts in DNA methylation and modifications to the proteins that package DNA, and they have been documented in response to several of the most common indoor and dietary mycotoxins.5PubMed. Role of epigenetics in mycotoxin toxicity: A review Whether these epigenetic shifts could prime the immune system toward autoimmunity over time is an open question, but the theoretical pathway exists.
Molecular Mimicry and Mistaken Identity
One of the best-understood routes from infection to autoimmunity is molecular mimicry. The idea is straightforward: if a piece of an invading organism looks similar enough to one of the body’s own proteins, the immune response aimed at the invader can accidentally target healthy tissue as well. This mechanism has been studied extensively with bacteria and viruses but less so with fungi.
There is, however, at least one study that directly tested this idea with fungal proteins. Researchers identified structural similarities between certain fungal proteins and a human protein called U1-70 kDa, which is a target of autoimmune attack in connective tissue diseases. Their data suggested that these fungal proteins could act as possible triggers for autoimmunity directed at U1-70 kDa through molecular mimicry.6PubMed. Potential role of molecular mimicry between human U1-70 kDa and fungal proteins in the development of T-cell mediated anti-U1-70 kDa autoimmunity This particular study focused on a protein relevant to mixed connective tissue disease rather than Sjögren’s specifically, but it demonstrates that the molecular mimicry mechanism is not limited to bacteria and viruses. The principle could apply to other autoimmune targets, including those attacked in Sjögren’s, though no one has yet shown this directly for the gland-specific antigens that characterize the disease.
What the Epidemiological Evidence Shows
If mold were clearly causing autoimmune diseases like Sjögren’s, you would expect to see clusters of cases in mold-exposed populations. The evidence on this is thin but not absent. A well-documented case series from Finland described what happened to employees of a health center after they moved into a new building that turned out to have significant moisture damage. Mold and actinobacteria were found in the flooring and wall insulation. All 34 workers in the building developed at least some rheumatic complaints. Several developed full-blown rheumatoid arthritis, others developed unclassifiable joint inflammation, and one developed vasculitis. Immune complex levels in the workers were elevated during their time in the building and dropped after it was closed for 18 months.7PubMed. Joint symptoms and diseases associated with moisture damage in a health center
That study did not report any cases of Sjögren’s syndrome specifically, and 34 people in a single building is far too small to draw general conclusions. But the pattern is striking: a population with no particular rheumatic predisposition developed a cluster of autoimmune and inflammatory joint problems that partially resolved when the mold exposure ended. The researchers concluded that the building itself, and probably the abnormal microbial growth within it, was the common triggering factor.
Broader population-level studies have found associations between indoor dampness and rheumatic diseases. A cross-sectional study of older adults in China tested for links between six different indoor dampness indicators and rheumatic diseases or symptoms, and found that dampness was strongly associated with these conditions.8PubMed. Association of indoor dampness indicators with rheumatic diseases/symptoms in older adults: A comparative cross-sectional study in Chongqing and Beijing Again, these studies deal with the rheumatic disease category broadly, not Sjögren’s in particular. But Sjögren’s sits within the same family of systemic autoimmune conditions, and the mechanisms of immune activation overlap.
Autoantibodies in Mold-Exposed People
One of the more suggestive pieces of evidence connecting mold exposure to autoimmunity comes from studies of people with dampness and mold hypersensitivity syndrome, sometimes called sick building syndrome in its early stages. Research into this condition has documented the appearance of autoantibodies in affected individuals. These include antibodies against myelin basic protein, smooth muscle cells, and antinuclear antibodies, which are the kind of markers typically associated with autoimmune diseases.9PubMed Central. The Roles of Autoimmunity and Biotoxicosis in Sick Building Syndrome as a “Starting Point” for Irreversible Dampness and Mold Hypersensitivity Syndrome
Antinuclear antibodies are particularly relevant here because they are a hallmark of Sjögren’s syndrome. Finding them in people exposed to mold-damaged buildings does not prove that mold causes Sjögren’s, but it does indicate that mold exposure can push the immune system in a direction that looks like the early stages of autoimmune disease. Whether that push ever results in a specific autoimmune diagnosis like Sjögren’s likely depends on the person’s genetic background, the duration and intensity of exposure, and other concurrent risk factors.
Molds as Part of a Broader Environmental Trigger Landscape
It is worth putting mold into context alongside other environmental triggers that have been discussed in autoimmunity research. A review of autoimmunity and the gut explicitly listed molds alongside chemicals, bacteria, and viruses as part of the vast number of possible environmental triggers for autoimmune disease.10PubMed Central. Autoimmunity and the gut This reflects the current scientific framing: mold is not considered a fringe hypothesis, but neither does it get special billing compared to viral infections, which have far more evidence behind them as triggers for Sjögren’s specifically. Epstein-Barr virus, for example, has been studied extensively in connection with Sjögren’s, and the infection-related risk factor identified in the meta-analysis of Sjögren’s risk factors was driven largely by viral and bacterial infections rather than fungal ones.2PubMed Central. Risk factors for primary Sjögren’s Syndrome: a systematic review and meta-analysis
The honest assessment is that mold occupies a space of biological plausibility without clinical confirmation. The immune mechanisms are real: mycotoxins activate inflammatory pathways, fungal proteins can trigger molecular mimicry, and mold-exposed people develop autoantibodies. But no one has followed a group of mold-exposed individuals long enough and in sufficient numbers to show that Sjögren’s develops at higher rates than expected. That kind of prospective cohort study would be expensive, logistically difficult, and ethically complicated to design.
When Mold Exposure Meets a Vulnerable Immune System
One area where the evidence is somewhat stronger, though still evolving, is the interaction between mold exposure and people who already have some degree of immune dysregulation. A review in the International Journal of Molecular Sciences noted that while the direct health effects of mold beyond allergic responses remain controversial, recent observations point to a particular importance of mold and mycotoxin exposure in people with pre-existing immune dysregulation. In these individuals, mold exposure may worsen underlying conditions including allergic and non-allergic chronic inflammatory diseases as well as autoimmune disorders.11PubMed Central. Mold, Mycotoxins and a Dysregulated Immune System: A Combination of Concern?
This is an important distinction. Someone with early or subclinical autoimmune activity might be more susceptible to the immune-disrupting effects of mold than a person with a fully healthy immune system. If you already carry genetic risk factors for Sjögren’s, or if your immune system is already producing low levels of the characteristic autoantibodies, mold exposure could theoretically act as an accelerant. The research so far does not prove this specifically for Sjögren’s, but the general principle that environmental insults hit harder when the immune system is already compromised is well established across autoimmune medicine.
Why This Question Is So Hard to Answer Definitively
Several features of both Sjögren’s syndrome and mold exposure make the question of causation genuinely difficult to settle. Sjögren’s develops slowly, often over years, and diagnosis typically comes long after the disease process has begun. By the time someone is diagnosed, reconstructing their environmental exposure history with any precision is nearly impossible. People move between buildings, mold exposure is rarely measured at the time it occurs, and the latency between an immune trigger and the appearance of clinical disease can be very long.
Mold exposure itself is poorly quantified in most research. Studies of damp buildings often document the presence of mold and dampness indicators but rarely measure individual-level mycotoxin exposure. The Finnish building cluster study, for example, confirmed mold in the building materials but could not tell you how much mycotoxin each worker actually inhaled or ingested. Without dose-response data, it is hard to distinguish “mold was present and people got sick” from “mold caused the sickness.”
There is also the confounding problem. Damp, moldy buildings often have other issues: volatile organic compounds off-gassing from water-damaged materials, bacterial contamination, dust mites thriving in humid environments, and psychological stress from living or working in visibly deteriorating spaces. Negative stressful life events alone raise the odds of developing Sjögren’s, as the meta-analysis showed.2PubMed Central. Risk factors for primary Sjögren’s Syndrome: a systematic review and meta-analysis Disentangling mold’s specific contribution from the web of co-occurring exposures in a sick building is a challenge that current study designs have not resolved.
Practical Considerations for People Living With Mold Exposure
If you are dealing with mold in your home or workplace and are concerned about autoimmune disease, the most grounded advice is to reduce your exposure regardless of whether a specific link to Sjögren’s has been proven. The respiratory and allergic effects of mold are well documented, and the emerging evidence about immune dysregulation adds another reason not to live with significant mold contamination if you can avoid it. Remediation of water-damaged buildings, improving ventilation, and controlling indoor humidity are standard public-health recommendations that apply here.
If you already have Sjögren’s syndrome or another autoimmune condition, the research suggesting that mold exposure may worsen pre-existing immune dysregulation is worth taking seriously even without definitive proof of causation. Chronic inflammation from any source, including environmental mycotoxin exposure, is unlikely to help an immune system that is already attacking itself. Discussing environmental exposures with your rheumatologist is reasonable, though be aware that some testing marketed to patients, particularly unvalidated urine mycotoxin panels, has been flagged by health authorities as unreliable for clinical diagnosis.
The Mycobiome and Emerging Research
A newer area of research that may eventually shed light on the mold-autoimmunity question involves the mycobiome, the community of fungi that naturally live in and on the human body. Just as the bacterial microbiome has been linked to autoimmune diseases, researchers are beginning to explore whether imbalances in the body’s fungal communities contribute to immune dysregulation. The oral mycobiome is of particular interest for Sjögren’s, since the disease directly affects the mouth and salivary glands, creating an environment where fungal overgrowth (especially Candida) is common.
Whether fungal dysbiosis in the mouth or gut can contribute to triggering or maintaining the autoimmune process in Sjögren’s is an active area of inquiry.12PubMed Central. The Human Mycobiome: Composition, Immune Interactions, and Impact on Disease This is a different question from inhaling mycotoxins in a damp building, but it connects to the broader idea that fungi interact with the human immune system in ways that are more complex than simple infection and clearance. It also raises the possibility that environmental mold exposure could shift the body’s fungal communities in ways that have downstream immune consequences, though this remains speculative.
The mycobiome research is still in early stages compared to the bacterial microbiome field, which itself is only a couple of decades old. But it represents probably the most promising avenue for understanding how fungal exposures, whether from the environment or from the body’s own microbial communities, could contribute to diseases like Sjögren’s. Researchers have the tools now to sequence fungal communities from patient samples and compare them to healthy controls, and those studies are underway for several autoimmune conditions. Whether Sjögren’s-specific findings emerge from this work is something to watch for in the coming years.